Physics Support for Intraprostatic Treatment of Patients with Locally Recurrent Prostate Cancer with the PSA-Activated Protoxin PRX302
Byline
A Boyer1 *, S Coffield1 , L Culp1 , A Frankel1 , N Merchant2 , R Abi-Habib2 , (1) Scott & White Memorial Hospital, Temple, Texas, (2) Protox Therapeutics Inc., Vancouver, British Columbia, CA